These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27771370)

  • 1. Novel non-β-lactam inhibitor of β-lactamase TEM-171 based on acylated phenoxyaniline.
    Grigorenko VG; Andreeva IP; Rubtsova MY; Deygen IM; Antipin RL; Majouga AG; Egorov AM; Beshnova DA; Kallio J; Hackenberg C; Lamzin VS
    Biochimie; 2017 Jan; 132():45-53. PubMed ID: 27771370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, SAR and molecular docking study of novel non-β-lactam inhibitors of TEM type β-lactamase.
    Antipin RL; Beshnova DA; Petrov RA; Shiryaeva AS; Andreeva IP; Grigorenko VG; Rubtsova MY; Majouga AG; Lamzin VS; Egorov AM
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1588-1592. PubMed ID: 28237762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.
    Chow DC; Rice K; Huang W; Atmar RL; Palzkill T
    ACS Infect Dis; 2016 Dec; 2(12):969-979. PubMed ID: 27756125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
    Faheem M; Rehman MT; Danishuddin M; Khan AU
    PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1.
    Christopeit T; Albert A; Leiros HS
    Bioorg Med Chem; 2016 Jul; 24(13):2947-2953. PubMed ID: 27184103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the discovery of metallo-β-lactamase inhibitors for β-lactam antibiotic-resistant reversing agents.
    Guo Z; Ma S
    Curr Drug Targets; 2014; 15(7):689-702. PubMed ID: 24666360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based efforts to optimize a non-β-lactam inhibitor of AmpC β-lactamase.
    Hendershot JM; Mishra UJ; Smart RP; Schroeder W; Powers RA
    Bioorg Med Chem; 2014 Jul; 22(13):3351-9. PubMed ID: 24835785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors.
    Sgrignani J; De Luca F; Torosyan H; Docquier JD; Duan D; Novati B; Prati F; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2016 Oct; 30(10):851-861. PubMed ID: 27632226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on β-lactamase inhibitor discovery and development.
    Docquier JD; Mangani S
    Drug Resist Updat; 2018 Jan; 36():13-29. PubMed ID: 29499835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing metallo-β-lactamases with molecular fragments identified by consensus docking.
    Klingler FM; Moser D; Büttner D; Wichelhaus TA; Löhr F; Dötsch V; Proschak E
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5243-6. PubMed ID: 26463134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communication between the active site and the allosteric site in class A beta-lactamases.
    Meneksedag D; Dogan A; Kanlikilicer P; Ozkirimli E
    Comput Biol Chem; 2013 Apr; 43():1-10. PubMed ID: 23314151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(Sulfamoylbenzoyl)-L-proline Derivatives as Potential Non-β-lactam ESBL Inhibitors: Structure-Based Lead Identification, Medicinal Chemistry and Synergistic Antibacterial Activities.
    Liu X; Dong S; Ma Y; Xu H; Zhao H; Gao Q
    Med Chem; 2019; 15(2):196-206. PubMed ID: 30112996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class A β-lactamases and inhibitors: In silico analysis of the binding mode and the relationship with resistance.
    Pereira R; Rabelo VW; Sibajev A; Abreu PA; Castro HC
    J Biotechnol; 2018 Aug; 279():37-46. PubMed ID: 29753682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a hidden site on class A beta-lactamases.
    Avci FG; Altinisik FE; Karacan I; Senturk Karagoz D; Ersahin S; Eren A; Sayar NA; Vardar Ulu D; Ozkirimli E; Sariyar Akbulut B
    J Mol Graph Model; 2018 Sep; 84():125-133. PubMed ID: 29960255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent docking of selected boron-based serine beta-lactamase inhibitors.
    Sgrignani J; Novati B; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2015 May; 29(5):441-50. PubMed ID: 25676821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.